333pcirculating Tumor Cell Count at Baseline Is an Independent Prognostic Factor from Pathological Complete Response among Patients Treated for Primary Inflammatory Her2-positive Breast Cancer: Survival Results of the Beverly-2 Study.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1093/annonc/mdu328.2

Topics

  • Presentations referencing similar topics